Vivek Shinde Patil
PhD
Co-Founder & CEO
Accomplished biotech professional and entrepreneur with expertise bringing products to market and startup commercialization and scale-up.
Our Team
Leadership with deep miRNA expertise
Our team combines scientific discovery, regulatory experience, clinical translation, and business development to advance precision RNA therapeutics.
Management
Anna Moore
PhD
Co-Founder & Pre-Clinical Advisor
Associate Dean for Research Development and Director of Precision Health Program at MSU. Successful startup commercialization, fundraising, and exits.
Elizabeth Quackenbush
MD PhD
Translational Medicine & Clinical Advisor
Physician scientist with 20+ years of leadership in drug development across preclinical discovery and late-stage clinical trials. Senior roles at Merck, Roche, Agennix, Celldex, and Elstar.
Advisors
Oncology & RNA expertise
Lubomir Nechev
PhD
Chief CMC Officer, Alnylam Pharmaceuticals.
Mike Exton
PhD
CEO at Lexicon Pharmaceuticals. Executive leadership at Novartis.
Maria Teresa Di Martino
PhD
Group Leader, Preclinical R&D, Magna Graecia University, Italy.
Pierfrancesco Tassone
MD
Full Professor and Director of Medical Oncology, Magna Graecia University, Italy.